Investinor — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Tribune Therapeutics ABtribunetx.cominMar 2025
Tribune Therapeutics is a preclinical biopharmaceutical company developing medicines that target CCN protein family signaling (such as CCN2/CTGF) to block fibrotic pathways.
BiotechHealthtech
Ole Kaasbøll(Co-founder)
Co-investorsHealthCapIndustrifondenLifeArc VenturesNovo Holdings
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.